11.11.2014 • News

Platform Specialty Chemicals to Launch IPO

With three major acquisitions under its belt this year, Miami, Florida-based Platform Specialty Chemicals has launched a $350 million initial public offering to cover its past purchases and fund further growth.

The ipo, for which a share price has not yet been announced, will follow a $300 million offering in May of this year and a $651 million offering in October.

The Miami chemical firm's purchases during 2014 include three agrochemicals business, including Belgium's Agriphar for $300 million, Ireland-based Arysta Life Science for $3.5 billion and Chemtura AgroSolutions, a subsidiary of US chemical producer Chemtura for $1 billion.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

29 April 2026 | This webinar explores how chemical industry organizations can design a digital‑ and AI‑ready operating model focused on clarity, usability, and measurable value.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read